Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 2/20 | 0.67 |
| ▸ | CA1 | P00915 | 2/20 | 0.65 |
| ▸ | CA2 | P00918 | 2/20 | 0.65 |
| ▸ | CA7 | P43166 | 2/20 | 0.65 |
| ▸ | CA9 | Q16790 | 2/20 | 0.65 |
| ▸ | CA12 | O43570 | 1/20 | 0.65 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.65 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | CASP3 | P42574 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.56 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.56 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7610770 | 1.00 | LTA4H (0.67) | LTA4HCA1CA2CA7CA9 | |
| SCHEMBL9151672 | 0.91 | CA1 (0.79) | CA1CA2CA7CA9CA12 | |
| SCHEMBL11580995 | 0.91 | CA1 (0.79) | LTA4HCA1CA2CA7CA9 | |
| SCHEMBL6733562 | 0.91 | CA1 (0.79) | CA1CA2CA7CA9CA12 | |
| SCHEMBL197522 | 0.91 | CA1 (0.79) | CA1CA2CA7CA9CA12 | |
| SCHEMBL166536 | 0.91 | CA1 (0.79) | LTA4HCA1CA2CA7CA9 | |
| SCHEMBL83811 | 0.91 | CA1 (0.79) | LTA4HCA1CA2CA7CA9 | |
| SCHEMBL18708707 | 0.90 | ACHE (0.71) | LTA4HCA1CA2CA7CA9 | |
| SCHEMBL12770837 | 0.90 | ACHE (0.71) | LTA4HCA1CA2CA7CA9 | |
| SCHEMBL15722134 | 0.90 | LTA4H (0.86) | LTA4HCA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230235115-A1 | ESTER COMPOUND AND RESIN COMPOSITION | AJINOMOTO CO., INC. (JP) | 2023-07-27 | — | — | US | disclosed |
| US-20180009949-A1 | DINADIC PHENYL AMINE REACTIVE ENDCAPS | THE BOEING COMPANY | 2018-01-11 | — | — | US | disclosed |
| US-20170260332-A1 | POLYARYLETHER KETONE IMIDE ADHESIVES | THE BOEING COMPANY | 2017-09-14 | — | — | US | disclosed |
| US-20170260432-A1 | POLYARYLETHER KETONE IMIDE SULFONE ADHESIVES | THE BOEING COMPANY | 2017-09-14 | — | — | US | disclosed |
| US-9670325-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2017-06-06 | — | — | US | disclosed |
| US-9670325-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2017-06-06 | — | — | US | disclosed |
| US-9505864-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2016-11-29 | — | — | US | disclosed |
| US-9505864-B2 | Nanomodified backbones for polyimides with difunctional and mixed-functionality endcaps | THE BOEING COMPANY (US) | 2016-11-29 | — | — | US | disclosed |
| US-20160208053-A1 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | THE BOEING COMPANY | 2016-07-21 | — | — | US | disclosed |
| US-20160208053-A1 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | THE BOEING COMPANY | 2016-07-21 | — | — | US | disclosed |
| US-20160060377-A1 | NANOMODIFIED BACKBONES FOR POLYIMIDES WITH DIFUNCTIONAL AND MIXED-FUNCTIONALITY ENDCAPS | THE BOEING COMPANY | 2016-03-03 | — | — | US | disclosed |
| US-20140113093-A1 | Polymers with reduced estrogenic activity | SOLVAY SPECIALITY POLYMERS USA, LLC (US) | 2014-04-24 | — | — | US | disclosed |
| US-20140113093-A1 | Polymers with reduced estrogenic activity | SOLVAY SPECIALITY POLYMERS USA, LLC (US) | 2014-04-24 | — | — | US | disclosed |
| WO-2012160172-A1 | POLYMERS WITH REDUCED ESTROGENIC ACTIVITY | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2012-11-29 | — | — | WO | disclosed |
| US-7825211-B2 | Single-step-processable polyimides | THE BOEING COMPANY (US) | 2010-11-02 | — | — | US | disclosed |
| US-7825211-B2 | Single-step-processable polyimides | THE BOEING COMPANY (US) | 2010-11-02 | — | — | US | disclosed |
| US-20080319159-A1 | SINGLE-STEP-PROCESSABLE POLYIMIDES | THE BOEING COMPANY | 2008-12-25 | — | — | US | disclosed |
| US-20080319159-A1 | SINGLE-STEP-PROCESSABLE POLYIMIDES | THE BOEING COMPANY | 2008-12-25 | — | — | US | disclosed |
| US-20080300374-A1 | DINADIC PHENYL AMINE REACTIVE ENDCAPS | THE BOEING COMPANY | 2008-12-04 | — | — | US | disclosed |
| US-20080300374-A1 | DINADIC PHENYL AMINE REACTIVE ENDCAPS | THE BOEING COMPANY | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180009949-A1 | DINADIC PHENYL AMINE REACTIVE ENDCAPS | PARN, AADAC, PARG | LTA4H 2466/4885CA1 1572/4885CA2 808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.